Fraser Cummings
0000-0002-9659-3247
Publication & Citation Trends
Publications
0 total
P80 Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – a prospective, real-world phase IV interventional study
Cited by 0
Semantic Scholar
P96 Patient benefits of switching from intravenous to subcutaneous infliximab
Cited by 1
Semantic Scholar
P109 Iron deficiency without anaemia is associated with reduced grip strength but not self-reported fatigue in people with Crohn’s in remission
Cited by 0
Semantic Scholar
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial OA
Cited by 67
Semantic Scholar
P107 Incidence of enteric infections in symptomatic inflammatory bowel disease (IBD)
Cited by 0
Semantic Scholar
P110 Iron deficiency and fatigue in inflammatory bowel disease: a systematic review
Cited by 0
Semantic Scholar
Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC) OA
Cited by 14
Semantic Scholar
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study OA
Cited by 28
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(136)
Microscopic Colitis
(71)
Biosimilars and Bioanalytical Methods
(33)
Immunodeficiency and Autoimmune Disorders
(20)
Liver Diseases and Immunity
(14)
Affiliations
National Health Service
Centre for Human Genetics
University of Ulster
Hampton University
Southampton Hospital